Integral Derivatives’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$258K Sell
4,146
-1,850
-31% -$133K 0.01% 541
2017
Q4
$435K Sell
5,996
-3,919
-40% -$285K 0.01% 756
2017
Q3
$806K Sell
9,915
-28,250
-74% -$2.23M 0.01% 571
2017
Q2
$3.07M Buy
38,165
+21,568
+130% +$1.7M 0.06% 205
2017
Q1
$1.3M Buy
16,597
+10,534
+174% +$841K 0.02% 443
2016
Q4
$478K Buy
+6,063
New +$491K 0.01% 739
2015
Q4
Sell
-2,098
Closed -$202K 1092
2015
Q3
$202K Sell
2,098
-4,400
-68% -$463K 0.01% 971
2015
Q2
$682K Sell
6,498
-1,500
-19% -$153K 0.02% 638
2015
Q1
$825K Buy
+7,998
New +$809K 0.02% 566

Other funds holding CVS

Integral Derivatives's CVS Position: Q1 2018 in Review

Integral Derivatives reduced its CVS Health (CVS) stake by 31% in Q1 2018, selling an estimated $133K and leaving 4,146 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #541.

Integral Derivatives first reported a position in CVS in Q1 2015 and has held it in 9 quarters since. The position peaked at $3.07M in Q2 2017. 1,550 funds tracked by Wall St. Rank hold CVS as of Q1 2018.

  • Integral Derivatives held 4,146 shares of CVS Health worth $258K as of Q1 2018.
  • Integral Derivatives sold 1,850 CVS Health shares in Q1 2018, an estimated $133K.
  • CVS Health made up 0.01% of Integral Derivatives's portfolio in Q1 2018, its #541 holding.
  • Integral Derivatives first reported a position in CVS Health in Q1 2015 and has held it in 9 quarters since.
  • Integral Derivatives's CVS Health position peaked at $3.07M in Q2 2017.
  • 1,550 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.